Cholelithiasis possibly induced by protease inhibitors in 3 patients [3]

Clinical Infectious Diseases

Volumn 36, Issue 11, 2003, Pages 1498-1500

  Siveke, J T ^a   Bogner, Johannes R ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; CYCLOPHOSPHAMIDE; DOXORUBICIN; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; PREDNISONE; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE; VINCRISTINE;

ACUTE PANCREATITIS; ADULT; AGED; B CELL LYMPHOMA; CASE REPORT; CHOLELITHIASIS; CHOLESTASIS; CLINICAL FEATURE; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; HYPERLIPOPROTEINEMIA; LETTER; LIPODYSTROPHY; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; CHOLELITHIASIS; HUMANS; INDINAVIR; MALE; MIDDLE AGED; PROTEASE INHIBITORS; RITONAVIR;

EID: 0038806642     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374875     Document Type: Letter

References (5)

1. Verdon R, Daudon M, Albessard F, et al. Indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus. Clin Infect Dis 2002; 35:e57-9.
2. From the Centeres for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269:729-730.
3. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356:1423-30.
4. Zucker SD, Qin X, Rouster SD, et al. Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci U S A 2001; 98:12671-6.
5. Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections. N Engl J Med 2001; 344:984-96.